Frequency and Role of CDKN2A Deletion in High-Risk Pituitary Neuroendocrine Tumors

The Prognostic Roles of the Ki-67 Proliferation Index, P53 Expression, Mitotic Index, and Radiological Tumor Invasion in Pituitary Adenomas

(2019) Rovshan Hasanov et al.   ENDOCRINE PATHOLOGY

The 2017 WHO classification of pituitary adenoma: overview and comments

(2018) Naoko Inoshita et al.   Brain Tumor Pathology

Aggressive and malignant pituitary tumours: state-of-the-art

(2018) Dorota Dworakowska et al.   ENDOCRINE-RELATED CANCER

Clinical outcomes in male patients with lactotroph adenomas who required pituitary surgery: a retrospective single center study

(2018) Winnie Liu et al.   Pituitary

Rater Reliability of the Hardy Classification for Pituitary Adenomas in the Magnetic Resonance Imaging Era

(2017) Michael Mooney et al.   Journal of Neurological Surgery Part B-Skull Base

Refractory pituitary adenoma: a novel classification for pituitary tumors

(2016) Congxin Dai et al.   Oncotarget

Genomic profiling reveals distinctive molecular relapse patterns inIDH1/2wild-type glioblastoma

(2014) Vera Riehmer et al.   GENES CHROMOSOMES & CANCER

Consistent and Differential Genetic Aberrations between Esophageal Dysplasia and Squamous Cell Carcinoma Detected By Array Comparative Genomic Hybridization

(2013) Z.-Z. Shi et al.   CLINICAL CANCER RESEARCH

CDKN2A/p16 Inactivation Mechanisms and Their Relationship to Smoke Exposure and Molecular Features in Non–Small-Cell Lung Cancer

(2013) Kit W. Tam et al.   Journal of Thoracic Oncology

Therapy of aggressive pituitary tumors

(2011) Annamaria Colao et al.   EXPERT OPINION ON PHARMACOTHERAPY

Genomic instability — an evolving hallmark of cancer

(2010) Simona Negrini et al.   NATURE REVIEWS MOLECULAR CELL BIOLOGY